Statin therapy fails to slow progression of atherosclerosis in pediatric lupus patients

Links shared publicly online about this topic.

0
total visits

Statin therapy fails to slow progression of atherosclerosis in pediatric lupus patients

Atorvastatin therapy was found to be ineffective in reducing atherosclerosis progression in children and adolescents with systemic lupus erythematosus (SLE). Results of the Atherosclerosis Prevention in Pediatric Lupus Erythematosus Trial, now available in Arthritis & Rheumatism, a journal published by Wiley-Blackwell on behalf of the American College of Rheumatology, report that the statin therapy did trend toward positive effect of treatment and may benefit patients with more severe SLE who we

View full resource at eurekalert.org

Tags: Heart Disease, Circulatory Disorders, Atherosclerosis, Cholesterol Medication, Lupus, Children's Health, Lipitor